Privilege Lessons From DC Circ.'s Victory for Boehringer Ingelheim in FTC Battle Over GC's Docs
The court's ruling that certain files belonging to Boehringer Ingelheim Pharmaceuticals Inc. and requested by the Federal Trade Commission are protected by the attorney-client privilege and thus do not have to be turned over to the agency provides some important takeaways for GCs.
June 22, 2018 at 02:26 PM
1 minute read
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All'Rocket Docket': EDVA Judge Controls Google's Fate in Ad Tech Monopoly Trial
4 minute readChastised by Judge, Authors' Lawyers Bring Boies Schiller Into Meta AI Copyright Suit
3 minute readLexisNexis Parent Company Latest to Be Hit With CIPA Lawsuit Over Web Tracking Software
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250